[Effect of cefuroxime on embryonic and fetal development in an experiment].
The direct and indirect effects of cefuroxime on the embryo and fetus were studied in vitro and in vivo at different gestation times. The placenta, liver and kidneys of the mother and fetus were investigated morphologically. It was shown that in a dose of 250 mg/kg the antibiotic did not induce disorders in the fetus development. The histological examination of the fetus placenta and liver revealed no changes as compared to the controls. However, in the renal tubules of the mother and fetus, pathological lesions in the form of the cytoplasm granular degeneration and nucleus swelling, lysis and necrosis were observed. These lesions were of a dose-dependent character. The possible nephrotoxic effect of cefuroxime prevents its use as a drug of choice in treatment of gestation pyelonephritis.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D002444:Cefuroxime / Q000633:toxicity*; D002511:Cephalosporins / Q000633:toxicity*; D046508:Culture Techniques; D004305:Dose-Response Relationship, Drug; D047108:Embryonic Development / Q000187:drug effects; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D005865:Gestational Age; D009024:Morphogenesis / Q000187:drug effects; D010929:Placentation / Q000187:drug effects; D011247:Pregnancy; D051381:Rats
D002511:Cephalosporins; D002444:Cefuroxime
Vliianie tsefuroksima na razvitie émbriona i ploda v éksperimente.